ArticleCancer immunology, immunotherapy : CII2006
ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank.
Article in Cancer immunology, immunotherapy : CII, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 39 citations in OpenAlex.
- TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.Journal for immunotherapy of cancer · 2023Article
- Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.Journal of clinical medicine · 2020Article
- Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.Oncoimmunology · 2020Article
- Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes.Cancer immunology, immunotherapy : CII · 2016Article
- The IPD and IMGT/HLA database: allele variant databases.Nucleic acids research · 2015Article
- Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.Cancer gene therapy · 2014Article
- Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.PloS one · 2013Article
- IPD--the Immuno Polymorphism Database.Nucleic acids research · 2013Article
- High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis.Journal of molecular medicine (Berlin, Germany) · 2012Article
- Effect of culture at low oxygen tension on the expression of heat shock proteins in a panel of melanoma cell lines.PloS one · 2012Article
- Article
- Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients.Proceedings of the National Academy of Sciences of the United States of America · 2010Article
- IPD--the Immuno Polymorphism Database.Nucleic acids research · 2010Article
- Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity.Cancer immunology, immunotherapy : CII · 2010Article
- The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.PloS one · 2009Article
- HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.Cancer immunology, immunotherapy : CII · 2009Review
- The European searchable tumour line database.Cancer immunology, immunotherapy : CII · 2009Review
- CellMiner: a relational database and query tool for the NCI-60 cancer cell lines.BMC genomics · 2009Article
- Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009Article
- The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines.Cancer immunology, immunotherapy : CII · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer immunologists working in humans often require panels of tumour cell lines expressing different combinations of HLA alleles and other characteristics. Sources of cell lines are usually large cell banks carrying little immunologically relevant information on the available cells and limited numbers of different lines from the same type of tumour. Access to cells with desired combinations of characteristics is, therefore, difficult. Here, we describe an interactive database of a large collection of melanoma cell lines which have been extensively characterised for HLA genotype and surface expression, oncogene and tumour antigen expression, cytokine secretion, surface molecule expression, adhesion to extracellular matrix components, cytokine gene polymorphisms and other factors of interest to immunologists. This enables investigators to search for cells with particular constellations of HLA alleles, tumour antigens, etc., and then request these from the cell bank. This European Searchable Tumour Cell Line and Data Bank (ESTDAB) was established as a Research Infrastructure of the European Commission. For access to the databank and further details, please go to http://www.ebi.ac.uk/ipd/estdab/ .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.